In addition, through bioinformatics analysis such as TCGA-RNA-seq and network pharmacology, the researchers concluded that luteolin may play a clinical role in anti-PC and 2019-nCoV disease by regulating the activities of core genes (MPO and FOS) (Ye et al., 2021). This evidence concerns the gene FOS and pachyonychia congenita.